LMAT - ルメイトレ・バスキュラ― （LeMaitre Vascular Inc.）LMATのニュース
LeMaitre: Remaining Constructive On Long-Term Valuations (NASDAQ:LMAT) 2023/03/03 09:44:07 Seeking Alpha
LeMaitre Vascular continues putting its balance sheet to effective use, investing in strategic areas to fund future growth. Find out why LMAT stock is a Buy.
LeMaitre Vascular, Inc. (LMAT) Q4 2022 Earnings Call Transcript 2023/02/26 17:43:02 Seeking Alpha
LeMaitre Vascular, Inc. (NASDAQ:NASDAQ:LMAT) Q4 2022 Earnings Conference Call February 23, 2023 5:00 PM ETCompany ParticipantsJ.J.
LeMaitre Vascular, Inc. 2022 Q1 - Results - Earnings Call Presentation (NASDAQ:LMAT) 2023/02/26 17:42:29 Seeking Alpha
The following slide deck was published by LeMaitre Vascular, Inc.
LeMaitre Vascular reports mixed Q4 earnings; initiates Q1 and FY23 outlook 2023/02/23 22:10:06 Seeking Alpha
LeMaitre Vascular press release (LMAT): Q4 GAAP EPS of $0.25 misses by $0.01.Revenue of $41M (+3.8% Y/Y) in-line.Business Outlook: Q1 2023 Guidance: Sales of $42.6M - $45.0M vs
LeMaitre Q4 2022 Financial Results 2023/02/23 21:03:00 GlobeNewswire
BURLINGTON, Mass., Feb. 23, 2023 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2022 results, announced a $0.14/share quarterly dividend (+12%) and provided guidance.
LeMaitre: Remaining Constructive On Long-Term Valuations (NASDAQ:LMAT) 2023/03/03 09:44:07 Seeking Alpha
LeMaitre Vascular continues putting its balance sheet to effective use, investing in strategic areas to fund future growth. Find out why LMAT stock is a Buy.
LeMaitre Vascular, Inc. (LMAT) Q4 2022 Earnings Call Transcript 2023/02/26 17:43:02 Seeking Alpha
LeMaitre Vascular, Inc. (NASDAQ:NASDAQ:LMAT) Q4 2022 Earnings Conference Call February 23, 2023 5:00 PM ETCompany ParticipantsJ.J.
LeMaitre Vascular, Inc. 2022 Q1 - Results - Earnings Call Presentation (NASDAQ:LMAT) 2023/02/26 17:42:29 Seeking Alpha
The following slide deck was published by LeMaitre Vascular, Inc.
LeMaitre Vascular reports mixed Q4 earnings; initiates Q1 and FY23 outlook 2023/02/23 22:10:06 Seeking Alpha
LeMaitre Vascular press release (LMAT): Q4 GAAP EPS of $0.25 misses by $0.01.Revenue of $41M (+3.8% Y/Y) in-line.Business Outlook: Q1 2023 Guidance: Sales of $42.6M - $45.0M vs
LeMaitre Q4 2022 Financial Results 2023/02/23 21:03:00 GlobeNewswire
BURLINGTON, Mass., Feb. 23, 2023 (GLOBE NEWSWIRE) -- LeMaitre (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2022 results, announced a $0.14/share quarterly dividend (+12%) and provided guidance.
LeMaitre Vascular Stock: 16% Return Objective (NASDAQ:LMAT) 2022/06/24 15:03:18 Seeking Alpha
LeMaitre has been beaten down lately however the pullback lends significant opportunity to add to a long-term compounder. Read more about LMAT stock here.
Vascular Grafts Global Market Report 2022 2022/05/26 12:33:00 GlobeNewswire
Major players in the vascular graft market are B. Braun, C. R. Bard, Cardinal Health, Cook Medical, Endologix, LeMaitre Vascular, Medtronic Plc, Getinge, Terumo Medical Corporation, and Gore Medical. Major players in the vascular graft market are B. Braun, C. R. Bard, Cardinal Health, Cook Medical, Endologix, LeMaitre Vascular, Medtronic Plc, Getinge, Terumo Medical Corporation, and Gore Medical.
LeMaitre to Present at Upcoming Investor Conferences 2022/05/16 20:58:00 GlobeNewswire
BURLINGTON, Mass., May 16, 2022 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two upcoming investor conferences.